FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2184006934> ?p ?o ?g. }

• W2184006934 endingPage "3575" @default.
• W2184006934 startingPage "3575" @default.
• W2184006934 abstract "To analyze the distribution of uridine diphosphate glucuronosyltransferase (UGT)1A1 gene polymorphisms in Chinese patients with extensive-stage small-cell lung cancer (E-SCLC), and to evaluate correlations between the UGT1A1 gene polymorphisms and toxicity, and efficacy of irinotecan (CPT-11) based regimen in the patients with E-SCLC.The study analyzed the distribution of UGT1A1*28/*6 gene polymorphisms by polymerase chain reaction amplification and pyrosequencing. The analysis of UGT1A1*28 and UGT1A1*6 gene polymorphisms was performed in 67 patients with E-SCLC admitted to the clinic in the Department of Oncology from June 2011 to January 2013. A total of 67 cases with E-SCLC treated with irinotecan (CPT-11)-based regimen were enrolled to observe the adverse events and efficacy during the chemotherapy, including objective response rate, progression-free survival (PFS) and overall survival (OS). The correlation between UGT1A1 gene polymorphisms and severe adverse events was analyzed. The influences of UGT1A1*6/*28 polymorphisms on objective response rate, PFS, and OS were also analyzed.The distribution of UGT1A1 genotypes among 67 patients was as follows: UGT1A1*28 wild-type (WT) genotype TA6/6 (56, 83.6%), heterozygous mutant genotype TA6/7 (11, 16.4%); UGT1A1*6 WT genotype G/G (45, 67.2%), heterozygous mutant genotype G/A (22, 32.8%); no significant difference of PFS and OS was observed between different genotypes. The incidence of grade 3 and 4 delayed diarrhea and neutropenia in the patients carrying UGT1A1*6 G/A mutation was higher than that in the WT genotype (36.4% vs 6.6% P=0.034; 27.2% vs 4.4% P=0.026, respectively). The incidence of grade 3 and 4 thrombocytopenia in the patients carrying UGT1A1*28 TA6/7 mutation was higher than that in the WT genotype (27.2% vs 1.8% P=0.017). The patients simultaneously carrying UGT1A1*28 TA6/7 and UGT1A1*6 G/A mutations were prone to suffering grade 3 and 4 delayed diarrhea and neutropenia.For irinotecan-based regimens in E-SCLC, the UGT1A1*28 and UGT1A1*6 locus mutations can be regarded as predictors for severe adverse events. We also found that neither clinical response nor prognosis was significantly associated with the UGT1A1 gene polymorphisms." @default.
• W2184006934 created "2016-06-24" @default.
• W2184006934 creator A5008283041 @default.
• W2184006934 creator A5025843427 @default.
• W2184006934 creator A5055962801 @default.
• W2184006934 creator A5062985196 @default.
• W2184006934 creator A5069879012 @default.
• W2184006934 creator A5084029581 @default.
• W2184006934 creator A5091081725 @default.
• W2184006934 date "2015-12-01" @default.
• W2184006934 modified "2023-09-26" @default.
• W2184006934 title "The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer" @default.
• W2184006934 cites W1641535438 @default.
• W2184006934 cites W1965482316 @default.
• W2184006934 cites W1976646314 @default.
• W2184006934 cites W1978662721 @default.
• W2184006934 cites W1978761887 @default.
• W2184006934 cites W1979685373 @default.
• W2184006934 cites W1982728538 @default.
• W2184006934 cites W2011980082 @default.
• W2184006934 cites W2014622726 @default.
• W2184006934 cites W2029130050 @default.
• W2184006934 cites W2049521952 @default.
• W2184006934 cites W2055257627 @default.
• W2184006934 cites W2058562246 @default.
• W2184006934 cites W2062905312 @default.
• W2184006934 cites W2072671258 @default.
• W2184006934 cites W2073683299 @default.
• W2184006934 cites W2089755320 @default.
• W2184006934 cites W2090367734 @default.
• W2184006934 cites W2103726865 @default.
• W2184006934 cites W2107891449 @default.
• W2184006934 cites W2114699219 @default.
• W2184006934 cites W2118170001 @default.
• W2184006934 cites W2119347977 @default.
• W2184006934 cites W2121503597 @default.
• W2184006934 cites W2122517534 @default.
• W2184006934 cites W2124867180 @default.
• W2184006934 cites W2128447158 @default.
• W2184006934 cites W2144233828 @default.
• W2184006934 cites W2166418266 @default.
• W2184006934 cites W2166716850 @default.
• W2184006934 cites W2170260373 @default.
• W2184006934 cites W2314927739 @default.
• W2184006934 doi "https://doi.org/10.2147/ott.s95149" @default.
• W2184006934 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4671801" @default.
• W2184006934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26664141" @default.
• W2184006934 hasPublicationYear "2015" @default.
• W2184006934 type Work @default.
• W2184006934 sameAs 2184006934 @default.
• W2184006934 citedByCount "20" @default.
• W2184006934 countsByYear W21840069342016 @default.
• W2184006934 countsByYear W21840069342017 @default.
• W2184006934 countsByYear W21840069342018 @default.
• W2184006934 countsByYear W21840069342019 @default.
• W2184006934 countsByYear W21840069342020 @default.
• W2184006934 countsByYear W21840069342021 @default.
• W2184006934 countsByYear W21840069342022 @default.
• W2184006934 crossrefType "journal-article" @default.
• W2184006934 hasAuthorship W2184006934A5008283041 @default.
• W2184006934 hasAuthorship W2184006934A5025843427 @default.
• W2184006934 hasAuthorship W2184006934A5055962801 @default.
• W2184006934 hasAuthorship W2184006934A5062985196 @default.
• W2184006934 hasAuthorship W2184006934A5069879012 @default.
• W2184006934 hasAuthorship W2184006934A5084029581 @default.
• W2184006934 hasAuthorship W2184006934A5091081725 @default.
• W2184006934 hasBestOaLocation W21840069341 @default.
• W2184006934 hasConcept C104317684 @default.
• W2184006934 hasConcept C121608353 @default.
• W2184006934 hasConcept C126322002 @default.
• W2184006934 hasConcept C135763542 @default.
• W2184006934 hasConcept C143998085 @default.
• W2184006934 hasConcept C2776256026 @default.
• W2184006934 hasConcept C2776694085 @default.
• W2184006934 hasConcept C2777063308 @default.
• W2184006934 hasConcept C2780259306 @default.
• W2184006934 hasConcept C2781413609 @default.
• W2184006934 hasConcept C31467283 @default.
• W2184006934 hasConcept C526805850 @default.
• W2184006934 hasConcept C54355233 @default.
• W2184006934 hasConcept C71924100 @default.
• W2184006934 hasConcept C86803240 @default.
• W2184006934 hasConcept C90924648 @default.
• W2184006934 hasConceptScore W2184006934C104317684 @default.
• W2184006934 hasConceptScore W2184006934C121608353 @default.
• W2184006934 hasConceptScore W2184006934C126322002 @default.
• W2184006934 hasConceptScore W2184006934C135763542 @default.
• W2184006934 hasConceptScore W2184006934C143998085 @default.
• W2184006934 hasConceptScore W2184006934C2776256026 @default.
• W2184006934 hasConceptScore W2184006934C2776694085 @default.
• W2184006934 hasConceptScore W2184006934C2777063308 @default.
• W2184006934 hasConceptScore W2184006934C2780259306 @default.
• W2184006934 hasConceptScore W2184006934C2781413609 @default.
• W2184006934 hasConceptScore W2184006934C31467283 @default.
• W2184006934 hasConceptScore W2184006934C526805850 @default.
• W2184006934 hasConceptScore W2184006934C54355233 @default.
• W2184006934 hasConceptScore W2184006934C71924100 @default.
• W2184006934 hasConceptScore W2184006934C86803240 @default.

• next